C

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Medical Science Liaison - Oncology, South Central

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeSan Antonio, TX, USA$160k - $220k

About the Job

Requirements

  • An advanced degree in clinical or medical science, with a PhD, MD, PharmD, MSN, PA, or NP credential, is required.
  • Maintain a driving record in accordance with Corcept vehicle policy.

Responsibilities

  • Model and promote Corcept’s key principles of effective collaboration, embracing possibilities, following the data, and leading by doing to support accountability, innovation, and trust.
  • Engage in clinically meaningful scientific discussions with thought leaders and healthcare providers in gynecological oncology and other malignancies to increase knowledge of Corcept and glucocorticoid receptor antagonism in oncology.
  • Support Corcept products through healthcare professional communication, education, and in-depth scientific presentations, proactively or in response to appropriate requests.
  • Respond to medical inquiries from healthcare professionals promptly and with scientific accuracy.
  • Engage in scientific exchange about Corcept’s non-clinical and clinical trial data and clinical development, and ask thoughtful questions of internal and external stakeholders.
  • Develop and maintain working relationships with thought leaders, patient advocacy organizations, and oncology associations, including GOG, ASCO, and regional organizations.
  • Capture, analyze, and compliantly communicate insights and intelligence from the medical and scientific community to inform company decisions; frame communications clearly and usefully.
  • Support company-sponsored clinical trials, investigator-initiated studies, scientific communications, publications, clinical and scientific education, advisory boards, and congresses.
  • Maintain scientific, clinical, and technical expertise in relevant therapeutic areas.
  • Critically review scientific literature and provide evidence-based insights.
  • Collaborate within Medical Affairs and cross-functionally with Clinical Development, Clinical Operations, Market Access, Marketing, Commercial, Data Analytics, and other Oncology functions; establish regular channels for sharing and synthesizing information compliantly.
  • Attend and participate in medical conferences, advisory boards, and other scientific events, and strategically identify key opinion leaders for advisory board participation.
  • Maintain the territory plan and adapt Team MSL plans proactively to changes in the internal and external environment.
  • Travel approximately 50–70% of the time.

Desired Qualifications

  • Demonstrate strong scientific oncology knowledge, including therapeutic landscapes, NCCN guidelines, clinical trial data, oncology cooperative groups, and NCI/NCCN cancer centers.
  • Demonstrate intellectual curiosity, change management, teamwork and collaboration, communication, achievement of results, decision-making, and clinical and scientific expertise.
  • Apply working knowledge of multidisciplinary functions in drug development, including clinical development, clinical operations, biostatistics, regulatory, and commercial functions.
  • Prioritize tasks and goals and ensure projects are completed on time, on target, and within budget.
  • Identify resources to accomplish priorities and work with the Medical Affairs team to ensure resources are available.
  • Understand change management and adapt to changing priorities, goals, and territory.
  • Demonstrate effective interpersonal and communication skills.
  • Provide feedback to the Medical Affairs trainer and Medical Affairs Field Directors to support quality improvement and excellence.
  • Use PowerPoint, Word, and Excel effectively to create and edit content with minimal assistance and attention to accuracy and detail.
  • Experience with Veeva CRM or another CRM, Veeva Vault, and SharePoint and/or BOX is preferred.
  • Have 1–3+ years of MSL experience and 2+ years of oncology experience.

About the Company

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Corcept Therapeutics develops and commercializes cortisol modulators to treat disorders caused by abnormal cortisol levels. Its core product, Korlym (mifepristone), blocks cortisol’s action by acting as a cortisol receptor antagonist and is approved for hypercortisolism in Cushing’s syndrome. The company differentiates itself with a dedicated focus on cortisol modulation, an extensive pipeline of proprietary molecules, and ongoing development beyond Korlym. Its goal is to improve outcomes for patients with cortisol-related disorders by expanding access to effective therapies and advancing new treatments.

Company size
501-1,000
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Corcept Therapeutics

See more jobs